Fibrinolytic therapy for parapneumonic empyema during pregnancy.

Abstract

Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate drainage and prevent the need for surgery. Herein, we describe the cases of two pregnant women with parapneumonic empyema who were successfully treated with intrapleural fibrinolytic therapy.

• Authors: Hakki Ulutas, Erdal Yekeler, Zafer Hasan Ali Sak, Ihsan Doru, Akin Kuzucu
• Journal: Respiratory medicine case reports (Respir Med Case Rep) Vol. 5 Pg. 55-8 ( 2012) ISSN: 2213-0071 [Print] England
• PMID: 26057709 (Publication Type: Journal Article)